Crossing Borders With Nathan Lustig

Laura Mendoza, Unima: Developing Low-Cost Diagnostics for 3 Billion People, Ep 108 Laura Mendoza was already working on solutions for tuberculosis, the leading infectious killer worldwide, before COVID-19 came along. As founder and CPO of biotech Unima, Laura develops fast and low-cost diagnostics for infectious diseases. Her solutions help decision-makers create better programs for the treatment and control of these diseases.   From the first mentions of coronavirus early in 2020, Laura and her team immediately understood the magnitude of the problem. Quickly shifting gears, Unima started to focus on solutions for COVID-19, such as molecular tests for antibody detection.   I sit down with Laura to talk about why she decided to tackle human health and how she became an entrepreneur while completing several Masters along the way. We also discuss the work Unima was doing before COVID-19 and what it’s like to raise money as a biotech company in Latin America. Tackling global health It had never crossed Laura’s